OpGen

OpGen Current Assets

The Current Assets of OpGen (OPGN) as of Oct 18, 2026 is 739,455.00 USD. In the previous year, Current Assets was 1.34 M USD — a change of -44.76% (lower).

Current Assets

739,455.00USD

YoY

-44.76%

Last updated:

Current Assets of OpGen is 2025 739,455.00 USD. Current Assets of OpGen was 2024 1.34 M USD. It decreases by -44.76% lower compared to the previous year.

The OpGen Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
6.08 M USD
Jan 1, 2019
6.67 M USD
Jan 1, 2020
16.89 M USD
Jan 1, 2021
39.74 M USD
Jan 1, 2022
10.66 M USD
Jan 1, 2023
1.58 M USD
Jan 1, 2024
1.34 M USD
Jan 1, 2025
739,455.00 USD
The OpGen Current Assets history
YEARCurrent AssetsYoY
739,455.00USD-44.76%
1.34 MUSD-15.27%
1.58 MUSD-85.17%
10.66 MUSD-73.19%
39.74 MUSD+135.33%
16.89 MUSD+153.30%
6.67 MUSD+9.73%
6.08 MUSD+59.31%
3.81 MUSD-36.55%
6.01 MUSD-39.19%
9.89 MUSD+448.06%
1.80 MUSD-14.55%
2.11 MUSD-77.68%
9.46 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Current Assets of OpGen is 739,455.00 USD in 2025.

Current Assets of OpGen changed from 1.34 M USD to 739,455.00 USD, representing a -44.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets OpGen since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's OpGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — OpGen

All Key Metrics — OpGen